Antinori A - Search Results

1

SARS-CoV-2 Specific Immune Response and Inflammatory Profile in Advanced HIV-Infected Persons during a COVID-19 Outbreak.

Vergori A, Boschini A, Notari S, Lorenzini P, Castilletti C, Colavita F, Matusali G, Tartaglia E, Gagliardini R, Boschi A, Cimini E, Maeurer M, Piselli P, Angeli L, Antinori A, Agrati C, Girardi E. Vergori A, et al. Among authors: antinori a. Viruses. 2022 Jul 20;14(7):1575. doi: 10.3390/v14071575. Viruses. 2022. PMID: 35891555 Free PMC article.

2

Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure.

Antinori A, Zaccarelli M, Cingolani A, Forbici F, Rizzo MG, Trotta MP, Di Giambenedetto S, Narciso P, Ammassari A, Girardi E, De Luca A, Perno CF. Antinori A, et al. AIDS Res Hum Retroviruses. 2002 Aug 10;18(12):835-8. doi: 10.1089/08892220260190308. AIDS Res Hum Retroviruses. 2002. PMID: 12201905

3

High incidence of tuberculin skin test conversion among HIV-infected individuals who have a favourable immunological response to highly active antiretroviral therapy.

Girardi E, Palmieri F, Zaccarelli M, Tozzi V, Trotta MP, Selva C, Narciso P, Petrosillo N, Antinori A, Ippolito G. Girardi E, et al. Among authors: antinori a. AIDS. 2002 Sep 27;16(14):1976-9. doi: 10.1097/00002030-200209270-00021. AIDS. 2002. PMID: 12351964 No abstract available.

4

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.

De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, Poggio A, Pagano G, Tositti G, Cadeo G, Macor A, Toti M, D'Arminio Monforte A; Italian Cohort Naive Antiretrovirals Study Group. De Luca A, et al. Among authors: antinori a. Arch Intern Med. 2002 Oct 14;162(18):2125-32. doi: 10.1001/archinte.162.18.2125. Arch Intern Med. 2002. PMID: 12374521

5

Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02).

Amendola A, Bordi L, Angeletti C, Visco-Comandini U, Abbate I, Cappiello G, Budabbus MA, Eljhawi OA, Mehabresh MI, Girardi E, Antinori A, Ippolito G, Capobianchi MR. Amendola A, et al. Among authors: antinori a. J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):488-94. doi: 10.1097/00126334-200212150-00006. J Acquir Immune Defic Syndr. 2002. PMID: 12473837

6

Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation.

Zaccarelli M, Perno CF, Forbici F, Cingolani A, Liuzzi G, Bertoli A, Trotta MP, Bellocchi MC, Di Giambenedetto S, Tozzi V, Gori C, D'Arrigo R, De Longis P, Noto P, Girardi E, De Luca A, Antinori A. Zaccarelli M, et al. Among authors: antinori a. Antivir Ther. 2003 Feb;8(1):51-6. Antivir Ther. 2003. PMID: 12713064

7

HIV Type 1 replication in cerebrospinal fluid of patients with AIDS-related non-Hodgkin's lymphoma receiving chemotherapy and antiretroviral therapy.

Giancola ML, Uccella I, Alba L, Lorenzini P, Soldani F, Capobianchi M, Ruco L, Perno CF, Antinori A. Giancola ML, et al. Among authors: antinori a. AIDS Res Hum Retroviruses. 2003 Dec;19(12):1091-5. doi: 10.1089/088922203771881185. AIDS Res Hum Retroviruses. 2003. PMID: 14709245

8

The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy.

Ciancio BC, Trotta MP, Lorenzini P, Forbici F, Visco-Comandini U, Gori C, Bonfigli S, Bellocchi MC, Sette P, D'Arrigo R, Tozzi V, Zaccarelli M, Boumis E, Narciso P, Perno CF, Antinori A. Ciancio BC, et al. Among authors: antinori a. Antivir Ther. 2003 Dec;8(6):611-6. Antivir Ther. 2003. PMID: 14760895

9

Reduced value of thallium-201 single-photon emission computed tomography in the management of HIV-related focal brain lesions in the era of highly active antiretroviral therapy.

Giancola ML, Rizzi EB, Schiavo R, Lorenzini P, Schininà V, Alba L, Del Grosso B, Gigli B, Rosati S, Mango L, Bibbolino C, Antinori A. Giancola ML, et al. Among authors: antinori a. AIDS Res Hum Retroviruses. 2004 Jun;20(6):584-8. doi: 10.1089/0889222041217446. AIDS Res Hum Retroviruses. 2004. PMID: 15242533

10

Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients.

Zaccarelli M, Tozzi V, Lorenzini P, Trotta MP, Forbici F, Visco-Comandini U, Gori C, Narciso P, Perno CF, Antinori A; Collaborative Group for Clinical Use of HIV Genotype Resistance Test (GRT) at National Institute for Infectious Diseases Lazzaro Spallanzani. Zaccarelli M, et al. Among authors: antinori a. AIDS. 2005 Jul 1;19(10):1081-9. doi: 10.1097/01.aids.0000174455.01369.ad. AIDS. 2005. PMID: 15958840

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

896 results

Search Page